Related Experiment Video

Updated: Mar 26, 2026

Merkel Cell Polyomavirus Infection and Detection
13:45

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

10.5K

Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma

Shakuntala H Mauzo1, Renata Ferrarotto2, Diana Bell3

  • 1Department of Pathology, The University of Texas Health Science Center, Houston, Texas, USA.

Journal of Clinical Pathology
|January 29, 2016
PubMed

Insights

Merkel cell carcinoma (MCC), an aggressive skin cancer, is being studied through clinical trials. Research into its molecular changes aims to improve treatments for recurrent or metastatic disease.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer.
  • It predominantly affects elderly and immunosuppressed populations.
  • Understanding MCC's molecular alterations is crucial for treatment development.

Purpose of the Study:

  • To review current understanding of Merkel cell carcinoma molecular alterations.
  • To discuss ongoing clinical trials for MCC treatment.
  • To highlight the potential impact of new research on patient outcomes.

Main Methods:

  • Review of existing literature on MCC molecular biology.
  • Analysis of data from ongoing clinical trials (chemotherapy, targeted therapy, immunotherapy).
  • Synthesis of findings to inform future research directions.

Main Results:

  • Multiple molecular alterations in MCC have been identified.
  • Clinical trials are actively investigating various therapeutic strategies.
  • Preliminary results from some studies are emerging, with more anticipated.

Conclusions:

  • Ongoing research and clinical trials are vital for advancing MCC treatment.
  • Further understanding of MCC biology may lead to improved patient outcomes.
  • The study underscores the importance of continued investigation into this rare cancer.
Keywords:
CARCINOMADERMATOPATHOLOGYNEUROENDOCRINE TUMOURSSKIN

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.9K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K